Siirry päänavigointiin Siirry hakuun Siirry pääsisältöön

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours

  • Olga Bugaeva*
  • , Pilvi Maliniemi
  • , Wenche S. Prestvik
  • , Eeva Leivo
  • , Nicolas Kluger
  • , Alexander Salava
  • , Sanna Virtanen
  • , Kirsi Jäntti
  • , Olli Saksela
  • , Kaisa Lehti
  • , Paula Kujala
  • , Kai Krohn
  • , Annamari Ranki
  • *Tämän työn vastaava kirjoittaja

Tutkimustuotos: ArtikkeliTieteellinenvertaisarvioitu

4 Sitaatiot (Scopus)
9 Lataukset (Pure)

Abstrakti

Melanoma is a highly metastatic tumour originating from neural crest-derived melanocytes. The aim of this study was to analyse the expression of neuron navigator 3 (NAV3) in relation to membrane type-1 matrix metalloproteinase MMP14, a major regulator of inva-sion, in 40 primary melanomas, 15 benign naevi and 2 melanoma cell lines. NAV3 copy number changes were found in 18/27 (67%) primary melanomas, so that deletions dominated (16/27 of samples, 59%). NAV3 protein was found to be localized at the leading edge of migrating melanoma cells in vitro. Silencing of NAV3 reduced both melanoma cell migration in 2-dimensio-nal conditions, as well as sprouting in 3-dimensional collagen I. NAV3 protein expression correlated with MMP14 in 26/37 (70%) primary melanomas. NAV3 and MMP14 were co-expressed in all tumours with Breslow thickness < 1 mm, in 11/23 of mid-thickness tumours (1–5 mm), but in only 1/6 samples of thick (> 5 mm) melanomas. Altogether, NAV3 number changes are frequent in melanomas, and NAV3 and MMP14, while expressed in all thin melanomas, are often downregu-lated in thicker tumours, suggesting that the lack of both NAV3 and MMP14 favours melanoma progression.

AlkuperäiskieliEnglanti
Artikkeliadv00883
Sivumäärä9
JulkaisuActa Dermato-Venereologica
Vuosikerta103
DOI - pysyväislinkit
TilaJulkaistu - 2023
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Rahoitus

The authors thank Kaija Järvinen, Alli Tallqvist and Anastasia Chernenko for excellent technical assistance, and the Biomedi-cum Imaging Unit (Biomedicum Helsinki) for providing imaging facilities. Funding: Finnish Cancer Foundation and Helsinki University Hospital Research Funds.

Julkaisufoorumi-taso

  • Jufo-taso 2

!!ASJC Scopus subject areas

  • Dermatology

Sormenjälki

Sukella tutkimusaiheisiin 'Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Siteeraa tätä